Letter to the EditorRegarding the impact of left ventricular size on response to cardiac resynchronization therapy
References (9)
- et al.
The impact of left ventricular size on response to cardiac resynchronization therapy
Am Heart J
(2011) - et al.
Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy
Heart Rhythm
(2011) - et al.
Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy
Am Heart J
(2007) - et al.
Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
J Am Coll Cardiol
(2011)
There are more references available in the full text version of this article.
Cited by (6)
A literature embedding model for cardiovascular disease prediction using risk factors, symptoms, and genotype information
2023, Expert Systems with ApplicationsCitation Excerpt :LONP1 is associated with left ventricular contractile dysfunction (Svaguša et al., 2020), which can lead to ventricular fibrillation. Although the role of MIR4660 has not been fully identified, some works (Anderson & Mohler, 2007; Santulli et al., 2012, 2014; Yang et al., 2007) have shown that miR-1 levels appear to be augmented in ventricular arrhythmias (Anderson & Mohler, 2007; Yang et al., 2007). HEBP1 is a biomarker of Alzheimer’s disease (Yagensky et al., n.d.), which increases the risk of atrial/ventricular diseases (Bardai et al., 2014; Martins et al., 2020).
Sympathetic nervous system signaling in heart failure and cardiac aging
2015, Pathophysiology and Pharmacotherapy of Cardiovascular DiseaseImpact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people
2014, Journal of Cardiovascular Translational ResearchAtrial fibrillation and microRNAs
2014, Frontiers in Physiology
Copyright © 2012 Mosby, Inc. All rights reserved.